Omnicare To Settle Kickback Allegations Case For $28M
The Justice Department investigated charges that the nursing home pharmacy accepted kickbacks from drugmaker Abbott Laboratories to prescribe an anti-seizure medication to senior patients.
Archives: Morning Breakouts
35,821 - 35,840 of 112,582 Results
-
-
Pfizer To Undercut J&J With New Remicade Biosimilar
Pfizer will sell its version of the drug at a 15 percent discount of Johnson & Johnson's blockbuster rheumatoid-arthritis treatment.
By brilabuskes -
Senator Calls Mylan’s Settlement ‘Unacceptable,’ Urges Justice Department To Reject It
Sen. Richard Blumenthal (D-Conn.) says the settlement contains no admission of wrongdoing. “DOJ must fulfill its responsibility to fully and fairly investigate the facts, establish intent, and punish wrongdoing to deter present and future bad actors," he wrote in the letter to the agency.
By brilabuskes -
Biden Strikes Hopeful Chord, While Acknowledging Challenges, In Final Moonshot Report
The vice president detailed improvements that have come from the cancer moonshot initiative so far and laid out ambitious projects for the upcoming years.
By brilabuskes -
Simple Choice Option Lets ACA Shoppers Make Apples-To-Apples Comparisons Between Plans
Officials say the new option will simplify shopping under the Affordable Care Act by reducing variation among plans. Meanwhile, UnitedHealth adjusts its forecast following its decision to drop out of the marketplaces, and the Koch brothers launch a million dollar ad campaign using Obamacare to target competitive Senate seats.
By brilabuskes -
First Edition: October 18, 2016
Today's early morning highlights from the major news organizations.
By brilabuskes -
Viewpoints: Evidence In Support Of Medicaid Expansion; Too Much Reporting On Quality?
A selection of opinions on health care from around the country.
-
State Highlights: Colorado Is Next Battleground For Aid-In-Dying Ballot Measure; Tenn. Task Force Makes Progress Over Nurse Credentialing
Outlets report on health news from Colorado, Tennessee, Connecticut, Georgia, Ohio and Florida.
By brilabuskes -
Hospital Roundup: Baltimore ERs ‘Row Upstream’ To Save Gunshot Victims; Calif. Voters Weigh Hospital Fee Measure
News outlets report on the latest developments related to hospitals in Maryland, California, New Hampshire, Florida, Ohio and Indiana.
By brilabuskes -
12 People Charged In $100M Health Fraud Involving Pharmacies And Military Health System
Federal prosecutors in Texas say the defendants allegedly sold soldiers expensive compounded products like pain and scar creams that were not needed.
By brilabuskes -
Microcephaly Before Zika
In 2006, Christine Grounds gave birth to her son Nicholas, who was diagnosed with microcephaly. The costs and difficulties of raising a child with the disease changed the course of their family's life.
By brilabuskes -
All Eyes Are On California To See If Raising Smoking Age Lives Up To ‘Life-Saving’ Promises
It's too early to tell if the measure to raise the smoking age to 21 will have lasting health benefits.
By brilabuskes -
New Generation Of Sperm Tests Aim To Feed ‘Big Hunger’ For Information On Male Infertility
The traditional sperm tests don't actually reveal much, especially when it comes to men who have normal sperm counts yet can't conceive. In other public health news, the election is causing stress for many Americans, a look at if hydration therapy actually works, research finds wearables become less accurate with more vigorous exercise and more.
By brilabuskes -
Marking 100 Years: Planned Parenthood Says Its Resolve Has Only Strengthened
Opponents decry the celebration as a "tragic milestone."
By brilabuskes -
Health System Scrambles To Meet Transgender Patients’ Needs
Hospitals and professional schools have begun training employees and students on transgender medicine, but struggles still remain.
By brilabuskes -
Potential Fallout From Calif. Ballot Initiative Has Pharma Sweating The Elections
A measure to curb drug prices, from such an influential state, could create a ripple effect for the industry that threatens its current status quo. Meanwhile, Valeant announces more price increases.
By brilabuskes -
With New Drug To Help Addicts, Pharma Companies Chase Profits From Opioid Epidemic
The pharmaceutical industry has taken to treating secondary symptoms of opioid abuse with more pills. Meanwhile, even as the U.S. tries to regulate the trade of chemicals used to make fentanyl, a new, extremely potent drug is hitting the streets.
By brilabuskes -
Concerns About Health Plans’ Choices And Costs Grow As Enrollment Season Nears
The health law's marketplaces will open Nov. 1 for customers to buy 2017 coverage, and many people are worried about steep increases in premiums and deductibles and the prospects of having to change plans. Also, a look at the varied experiences of insurers serving those marketplaces.
By brilabuskes -
Biden To Push Lame-Duck Congress For Cancer ‘Moonshot’ Funding
The vice president will deliver his final report, outlining the challenges that face cancer researchers in its goal to make a decade’s worth of progress against the disease in just five years.
By brilabuskes -
Administration Finalizes Medicare Rules Tying Bonuses, Penalties To Doctors’ Performance
An early draft of the rule sparked an outcry from physician groups that feared doctors in small medical practices would suffer under the new formula, but Centers for Medicare & Medicaid Services officials sought to allay those concerns by making it easy to avoid penalties in the first year.
By brilabuskes